701-1383

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2013-02-04

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-03-23 (study day 48.0); relationship: POSSIBLE

mild assessed

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-12 (study day 68.0); relationship: POSSIBLE

mild assessed

Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-12 (study day 68.0); relationship: POSSIBLE

moderate assessed

Moderate APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-12 (study day 68.0); relationship: POSSIBLE

mild assessed

Mild APPLICATION SITE PAIN — outcome: RECOVERED/RESOLVED; onset 2013-02-07 (study day 4.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-02-07 (study day 4.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-23 (study day 48.0); relationship: POSSIBLE

moderate assessed

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-23 (study day 48.0); relationship: POSSIBLE

mild assessed

Mild APPLICATION SITE VESICLES — outcome: RECOVERED/RESOLVED; onset 2013-05-07 (study day 93.0); relationship: POSSIBLE

mild assessed

Mild CHEST DISCOMFORT — outcome: RECOVERED/RESOLVED; onset 2013-06-24 (study day 141.0); relationship: NONE

moderate assessed

Moderate COUGH — outcome: RECOVERED/RESOLVED; onset 2013-07-17 (study day 164.0); relationship: NONE

mild assessed

Mild HEADACHE — outcome: RECOVERED/RESOLVED; onset 2013-06-24 (study day 141.0); relationship: NONE

Data queries

No data queries.